Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Anal Bioanal Chem ; 404(9): 2527-37, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22526652

RESUMEN

This critical review presents challenges and strategies in the detection of viral contaminants in food products. Adenovirus, caliciviruses, enteroviruses, and hepatitis A are emerging contaminant viruses. These viruses contaminate a variety of food products, including fruits, vegetables, shellfish, and ready-to-eat processed foods. The diversity of targets and sample matrices presents unique challenges to virus monitoring that have been addressed by a wide array of processing and detection methods. This review covers sample acquisition and handling, virus recovery/concentration, and the determination of targets using molecular biology and mass-spectrometric approaches. The concentration methods discussed include precipitation, antibody-based concentration, and filtration; the detection methods discussed include microscopy, polymerase chain reaction, nucleic acid sequence-based amplification, and mass spectrometry.


Asunto(s)
Análisis de los Alimentos/métodos , Contaminación de Alimentos/análisis , Alimentos/virología , Virus/aislamiento & purificación , Animales , Humanos , Espectrometría de Masas/métodos , Reacción en Cadena de la Polimerasa/métodos , Replicación de Secuencia Autosostenida/métodos , Virosis/virología
4.
Amino Acids ; 33(1): 151-5, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16955228

RESUMEN

Our purpose was to determine the blood amino acid concentration during insulin induced hypoglycemia (IIH) and examine if the administration of alanine or glutamine could help glycemia recovery in fasted rats. IIH was obtained by an intraperitoneal injection of regular insulin (1.0 U/kg). The blood levels of the majority of amino acids, including alanine and glutamine were decreased (P < 0.05) during IIH and this change correlates well with the duration than the intensity of hypoglycemia. On the other hand, the oral and intraperitoneal administration of alanine (100 mg/kg) or glutamine (100 mg/kg) accelerates glucose recovery. This effect was partly at least consequence of the increased capacity of the livers from IIH group to produce glucose from alanine and glutamine. It was concluded that the blood amino acids availability during IIH, particularly alanine and glutamine, play a pivotal role in recovery from hypoglycemia.


Asunto(s)
Alanina/sangre , Glucemia/biosíntesis , Gluconeogénesis/efectos de los fármacos , Glutamina/sangre , Hipoglucemia/sangre , Insulina/farmacología , Hígado/efectos de los fármacos , Aminoácidos/sangre , Animales , Glucemia/análisis , Combinación de Medicamentos , Hipoglucemia/inducido químicamente , Inyecciones Intraperitoneales , Hígado/metabolismo , Masculino , Ratas , Ratas Wistar
5.
Cell Biochem Funct ; 25(2): 211-6, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-16397910

RESUMEN

The acute effects of isolated and combined L-alanine (L-Ala) and L-glutamine (L-Gln) on liver gluconeogenesis, ureagenesis and glycaemic recovery during short-term insulin-induced hypoglycaemia (IIH) were investigated. For this purpose, 24-h fasted rats that received intraperitoneal injection of regular insulin (1.0 U/Kg) were investigated. The control group (COG group) were represented by rats which received saline. The studies were performed 30 min after insulin (IIH group) or saline (COG group) injection. Livers from IIH and COG groups were perfused with basal or saturating levels of L-Ala, L-Gln or L-Gln + L-Ala (L-G + L-A). The production of glucose, urea, L-lactate and pyruvate in livers from IIH and COG group were markedly increased (p < 0.001) when perfused with saturating levels of L-Ala, L-Gln or L-G + L-A compared with basal levels of the same substrates. In addition, livers from IIH rats showed greater ability in producing glucose and urea from saturating levels of L-Ala compared with L-Gln or L-G + L-A. In agreement with these results, the oral administration of L-Ala (100 mg/kg) promoted better glycaemic recovery than L-Gln (100 mg/kg) or the combination of L-G (50 mg/kg) + L-A (50 mg/kg). It can be concluded that L-Ala, but not L-Gln or L-G + L-A could help glycaemic recovery by a mechanism mediated, partly at least, by the increased gluconeogenic and ureagenic efficiency of L-Ala.


Asunto(s)
Alanina/administración & dosificación , Gluconeogénesis/efectos de los fármacos , Glutamina/administración & dosificación , Hipoglucemia/tratamiento farmacológico , Hipoglucemia/metabolismo , Hígado/efectos de los fármacos , Alanina/sangre , Animales , Glucemia/análisis , Glucemia/biosíntesis , Diabetes Mellitus Experimental , Combinación de Medicamentos , Glutamina/sangre , Hipoglucemia/inducido químicamente , Insulina , Ácido Láctico/metabolismo , Hígado/metabolismo , Masculino , Ácido Pirúvico/metabolismo , Ratas , Ratas Wistar , Urea/metabolismo
6.
Internist (Berl) ; 47(1): 39-46, 2006 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-16247632

RESUMEN

In hematological malignancies, gene expression profiling using DNA-microarrays led to the discovery of novel lymphoma and leukemia subgroups. The heterogeneous entity of diffuse large B-cell lymphoma could be subdivided into the germinal center B-cell-like and the activated B-cell-like subtype which differ in pathogenesis and clinical behavior. In leukemia, existing entities defined by morphological, cytogenetic, molecular and immunophenotypic criteria were confirmed on the global gene expression level; in addition, new important molecular subgroups could be identified. In retrospective clinical lymphoma and leukemia studies, robust gene expression signatures were discovered that predict the clinical course at the time of diagnosis. Given the huge potential of the DNA-microarray technology, application in the routine diagnostic setting appears possible.


Asunto(s)
Biomarcadores de Tumor/análisis , Leucemia/diagnóstico , Leucemia/metabolismo , Linfoma/diagnóstico , Linfoma/metabolismo , Proteínas de Neoplasias/análisis , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Perfilación de la Expresión Génica/métodos , Humanos , Análisis de Secuencia por Matrices de Oligonucleótidos/instrumentación , Análisis de Secuencia por Matrices de Oligonucleótidos/tendencias
7.
Mol Gen Genet ; 143(1): 113-8, 1975 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-1214779

RESUMEN

The three haploid yeast strains T2tmpl1-3, T2tmp1-1, and T6tmp1-51 auxotrophic for 5'-dTMP differ in their requirement for thymidylate: 72, 16, and 3 mug 5'-dTMP/ml will restore optimal growth, respectively. Thymidylate low requirement in strain T2tmp1-1 and T6tmp1-51 is termed tlrA and tlrC, respectively. When the growth medium is made 5 x 10(-4) M for 5'-dTMP only strain T6tmp1-51 is severely inhibited in RNA and DNA synthesis. This inhibition is reversible after removal of excessive 5'-dTMP. The inhibitory characteristic is in marked contrast to "thymineless death" due to the lack of 5'-dTMP in strain T6tmp1-51 where only DNA synthesis stops while RNA synthesis continues. The inhibitory effect of 5 x 10(-4) M 5'-dTMP is not due to the 5'-dTMP auxotrophy but to the thymidylate low requiring character (tlrC) in strain T6tmp1-51. The arrest of RNA and DNA synthesis by high concentrations of exogenous 5'-dTMP suggests a regulatory role of either the mono- or triphosphate on nucleoside or nucleotide biosynthesis in yeast.


Asunto(s)
ADN/biosíntesis , ARN/biosíntesis , Nucleótidos de Timina/farmacología , Levaduras/metabolismo , Relación Dosis-Respuesta a Droga , Nucleótidos de Timina/metabolismo , Levaduras/efectos de los fármacos , Levaduras/crecimiento & desarrollo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...